BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ma KW, She WH, Chan ACY, Cheung TT, Fung JYY, Dai WC, Lo CM, Chok KSH. Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population. World J Gastrointest Oncol 2019; 11(4): 322-334 [PMID: 31040897 DOI: 10.4251/wjgo.v11.i4.322]
URL: https://www.wjgnet.com/1948-5204/full/v11/i4/322.htm
Number Citing Articles
1
Abdulahad Abdulrab Mohammed Al‐Ameri, Xuyong Wei, Xue Wen, Qiang Wei, Haijun Guo, Shusen Zheng, Xiao Xu. Systematic review: risk prediction models for recurrence of hepatocellular carcinoma after liver transplantationTransplant International 2020; 33(7): 697 doi: 10.1111/tri.13585
2
Jian-Hua Li, Tuo Chen, Hao Xing, Rui-Dong Li, Cong-Huan Shen, Quan-Bao Zhang, Yi-Feng Tao, Zheng-Xin Wang. The AGH score is a predictor of disease-free survival and targeted therapy efficacy after liver transplantation in patients with hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2023; 22(3): 245 doi: 10.1016/j.hbpd.2022.04.003
3
Walaa Abdelhamed, Mohamed El-Kassas. Hepatocellular carcinoma recurrence: Predictors and managementLiver Research 2023; 7(4): 321 doi: 10.1016/j.livres.2023.11.004
4
Pak Chiu Wong, Wong Hoi She, Ka Wing Ma, Sui Ling Sin, Tiffany Cho Lam Wong, Wing Chiu Dai, Tan To Cheung, Albert Chi Yan Chan, Chung Mau Lo. Impact of Time to Recurrence on Survival Outcome of Salvage Liver TransplantationJournal of Gastrointestinal Surgery 2022; 26(4): 813 doi: 10.1007/s11605-021-05146-3
5
Astrid Herrero, Lucile Boivineau, Gianluca Cassese, Eric Assenat, Benjamin Riviere, Stéphanie Faure, José Ursic Bedoya, Fabrizio Panaro, Boris Guiu, Francis Navarro, Georges-Philippe Pageaux. Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular CarcinomaTransplant International 2022; 35 doi: 10.3389/ti.2022.10412
6
Helena Degroote, Anja Geerts, Xavier Verhelst, Hans Van Vlierberghe. Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver TransplantationCancers 2022; 14(12): 2973 doi: 10.3390/cancers14122973
7
Michele Finotti, Alessandro Vitale, Michael Volk, Umberto Cillo. A 2020 update on liver transplant for hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2020; 14(10): 885 doi: 10.1080/17474124.2020.1791704
8
Jordan Boeira dos Santos, Rodrigo Tzovenos Starosta, Emily Ferreira Salles Pilar, Jefferson Daniel Kunz, Joelson Tomedi, Carlos Thadeu Schmidt Cerski, Rúbia Denise Ruppenthal. Nuclear morphometry and chromatin texture changes in hepatocellular carcinoma samples may predict outcomes of liver transplanted patientsBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02262-5
9
Mohamad Mouchli, Shravani Reddy, Miranda Gerrard, Lisa Boardman, Marrieth Rubio. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma." Review articleAnnals of Hepatology 2021; 22: 100249 doi: 10.1016/j.aohep.2020.08.067
10
Maria C. van Hooff, Milan J. Sonneveld, Jan N. Ijzermans, Michail Doukas, Dave Sprengers, Herold J. Metselaar, Caroline M. den Hoed, Robert A. de Man. External Validation of the RETREAT Score for Prediction of Hepatocellular Carcinoma Recurrence after Liver TransplantationCancers 2022; 14(3): 630 doi: 10.3390/cancers14030630
11
Frédérique Priem, Pierre I. Karakiewicz, Michael McCormack, Lynda Thibeault, Luc Massicotte. Validation of 5 models predicting transfusion, bleeding, and mortality in liver transplantation: an observational cohort studyHPB 2022; 24(8): 1305 doi: 10.1016/j.hpb.2022.01.002
12
Dimitrios Papaconstantinou, Diamantis I Tsilimigras, Timothy M Pawlik. Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and TreatmentJournal of Hepatocellular Carcinoma 2022; : 947 doi: 10.2147/JHC.S342266